Covid-19: Expert panel rejects Dr Reddy’s proposal for full approval of remdesivir
After detailed deliberation, the committee did not recommend for grant of full marketing authorisation and opined that approval for Restricted Emergency use of the drug should continue,' the expert committee's meeting states
NEW DELHI: An expert panel at Central Drugs Standard Control Organisation rejected Dr Reddy’s Laboratories’ proposal for a full approval for remdesivir, saying that the restricted emergency use for the drug should instead continue.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more